Quantinno Capital Management
GSK icon

Quantinno Capital Management’s GSK GSK Stock Holding History

Quantinno Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$21.9M Buy
453,930
+29,168
+7% +$1.49M 0.02% 778
2026
Q2 		$22.3M Buy
424,762
+54,244
+15% +$2.87M 0.03% 680
2026
Q1 		$20.4M Buy
370,518
+48,829
+15% +$2.65M 0.03% 609
2025
Q4 		$15.8M Buy
321,689
+71,471
+29% +$3.33M 0.03% 608
2025
Q3 		$10.8M Buy
250,218
+61,125
+32% +$2.39M 0.03% 636
2025
Q2 		$7.26M Buy
189,093
+61,358
+48% +$2.34M 0.03% 660
2025
Q1 		$4.95M Buy
127,735
+20,982
+20% +$768K 0.03% 655
2024
Q4 		$3.61M Buy
106,753
+6,948
+7% +$250K 0.04% 611
2024
Q3 		$4.08M Sell
99,805
-2,880
-3% -$118K 0.05% 449
2024
Q2 		$3.95M Buy
102,685
+8,041
+8% +$338K 0.07% 321
2024
Q1 		$4.06M Buy
94,644
+10,642
+13% +$439K 0.09% 256
2023
Q4 		$3.11M Buy
84,002
+17,792
+27% +$639K 0.11% 227
2023
Q3 		$2.4M Buy
66,210
+49,367
+293% +$1.75M 0.11% 234
2023
Q2 		$600K Buy
16,843
+3,211
+24% +$115K 0.03% 576
2023
Q1 		$485K Buy
13,632
+1,515
+13% +$53K 0.03% 585
2022
Q4 		$426K Buy
+12,117
New +$404K 0.03% 583

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
JTC Employer Solutions Trustee
JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $46.6B AUM 32.12% 1-Year Est. Return

Quantinno Capital Management's GSK Position: Q3 2026 in Review

Quantinno Capital Management increased its GSK (GSK) stake by 6.9% in Q3 2026, buying an estimated $1.49M and bringing the position to 453,930 shares worth $21.9M. The position accounts for 0.02% of the portfolio, ranked #778.

Quantinno Capital Management first reported a position in GSK in Q4 2022 and has held it in 16 quarters since. The position peaked at $22.3M in Q2 2026. 854 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Quantinno Capital Management held 453,930 shares of GSK worth $21.9M as of Q3 2026.
  • Quantinno Capital Management bought 29,168 GSK shares in Q3 2026, an estimated $1.49M.
  • GSK made up 0.02% of Quantinno Capital Management's portfolio in Q3 2026, its #778 holding.
  • Quantinno Capital Management first reported a position in GSK in Q4 2022 and has held it in 16 quarters since.
  • Quantinno Capital Management's GSK position peaked at $22.3M in Q2 2026.
  • 854 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.